Crystal Yeager
Medical · Manchester, KYNPI 1356389514
Payments from drug & device makers
Across 126 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$539
- Lilly USA, LLC$241
- Novo Nordisk$193
- Merck$178
- Amgen$146
- GSK$127
- plus $699 from 14 others
What the payments were for
- Food & beverage$2,123100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $539 |
| Lilly USA, LLC | 18 | $241 |
| Novo Nordisk | 10 | $193 |
| Merck | 10 | $178 |
| Amgen | 2 | $146 |
| GSK | 8 | $127 |
| AstraZeneca | 7 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $94 |
| Ardelyx, Inc. | 4 | $76 |
| Pfizer | 5 | $70 |
| Bayer | 3 | $58 |
| Optinose US, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $53 |
| Astellas Pharma US Inc | 3 | $44 |
| Boehringer Ingelheim | 2 | $28 |
| Nestle Healthcare Nutrition Inc. | 2 | $27 |
| Shield Therapeutics Inc | 1 | $25 |
| Medtronic | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIMOVIG$123
How this compares
$2,123 in reported general payments places this provider in the 65th percentile of 222 medical providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 90 | $104,512 |
| JardianceEmpagliflozin | 152 | $99,980 |
| LinzessLinaclotide | 144 | $81,775 |
| XifaxanRifaximin | 25 | $78,600 |
| EliquisApixaban | 124 | $75,007 |
| JanuviaSitagliptin Phosphate | 120 | $71,695 |
| TrulicityDulaglutide | 26 | $26,909 |
| Spiriva HandihalerTiotropium Bromide | 42 | $25,668 |
| MounjaroTirzepatide | 20 | $20,358 |
| Spiriva RespimatTiotropium Bromide | 33 | $17,100 |
| TradjentaLinagliptin | 30 | $15,947 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $14,179 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 464 | $14,058 |
| MovantikNaloxegol Oxalate | 33 | $13,342 |
| FarxigaDapagliflozin Propanediol | 17 | $13,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Stiolto Respimat, Combivent Respimat | $28 | $148,742244 claims |
| Novo NordiskOzempic | $193 | $104,51290 claims |
| AbbVieLinzess | $539 | $81,775144 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $94 | $78,60025 claims |
| PfizerEliquis | $70 | $75,007124 claims |
| MerckJanuvia | $178 | $71,695120 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $241 | $47,26746 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $127 | $22,60049 claims |
| AstraZenecaFarxiga | $106 | $13,14117 claims |
| NovartisEntresto | $14 | $9,59215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 222 medical providers in Kentucky.
Other medical in Manchester
- Mikal BaileyPaducah$84K
- Kyle HeraldBowling Green$65K
- Chasity HesterLexington$16K
- Alexandra HuettLouisville$13K
- Danny ThackerFrankfort$11K
- Jessica FrizzellPaducah$10K
- Terry SmithHazard$10K
- Ashley HenegarGeorgetown$10K
- Rachel CrowleyPaducah$8K
- Allison ScottLexington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.